Request Deal Involvement

A consortium of investors led a $112 Series B funding round in Neumora Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

1AB

pr advisors

1AB

or

Principals

ARCH VENTURE PARTNERS

bidder

ARCH VENTURE PARTNERS

AMGEN INC

bidder

AMGEN INC

NEWPATH PARTNERS

bidder

NEWPATH PARTNERS

ALTITUDE LIFE SCIENCE VENTURES

bidder

ALTITUDE LIFE SCIENCE VENTURES

F-PRIME CAPITAL

bidder

F-PRIME CAPITAL

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

NEUMORA THERAPEUTICS

target

NEUMORA THERAPEUTICS

ABU DHABI GROWTH FUND

bidder

ABU DHABI GROWTH FUND

EXOR VENTURES

bidder

EXOR VENTURES

MUBADALA CAPITAL

bidder

MUBADALA CAPITAL

POLARIS PARTNERS

bidder

POLARIS PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - A consortium of investors led a $112 Series B funding round in Neumora Therapeutics.